Literature DB >> 14975559

Pericardial fluid level of heart-type cytoplasmic fatty acid-binding protein (H-FABP) is an indicator of severe myocardial ischemia.

Keiichi Tambara1, Masatoshi Fujita, Shoichi Miyamoto, Kazuhiko Doi, Kazunobu Nishimura, Masashi Komeda.   

Abstract

BACKGROUND: Heart-type cytoplasmic fatty acid-binding protein (H-FABP) has been reported as a sensitive and specific marker for the early diagnosis of acute myocardial infarction. Our hypothesis was that serum or pericardial fluid levels of H-FABP can reflect not only myocardial infarction but also myocardial ischemia.
METHODS: A total of 34 patients with unstable angina, who had anginal symptoms and/or ST-changes in ECG monitoring within 24 h before operation, were classified into group A (n=17), and those without these symptoms and changes into group B (n=17). Blood and pericardial fluid samples were obtained immediately after median sternotomy, and serum and pericardial fluid levels of creatine kinase-MB, cardiac troponin-T, and H-FABP were measured.
RESULTS: Serum H-FABP levels were slightly elevated compared with their normal values in both groups. While they showed no difference between groups A and B (group A vs. B: 8.5+/-1.0 vs. 7.1+/-0.7 ng/ml, P=0.25), pericardial fluid levels of H-FABP were significantly higher in group A than in group B (16.3+/-2.0 vs. 9.6+/-1.0 ng/ml, P=0.0046). H-FABP showed a weak correlation between its serum levels and pericardial fluid levels (r=0.40).
CONCLUSIONS: Pericardial fluid levels of H-FABP reflect myocardial ischemia occurring within 24 h of their measurements. H-FABP may be secreted into the interstitial space by increased permeability of the myocardial cell membrane associated with severe myocardial ischemia. Thus, pericardial fluid reflects pathophysiological conditions of cardiomyocytes more sensitively than circulating blood.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14975559     DOI: 10.1016/S0167-5273(03)00219-5

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

1.  Serum heart-type fatty acid binding protein levels in acromegaly patients.

Authors:  M Ozbek; M Erdogan; M Dogan; E Akbal; M A Ozturk; K Ureten
Journal:  J Endocrinol Invest       Date:  2010-09-09       Impact factor: 4.256

2.  Serum heart type fatty acid binding protein levels in metabolic syndrome.

Authors:  Erdem Akbal; Mustafa Özbek; Fahri Güneş; Ömer Akyürek; Kemal Üreten; Tuncay Delibaşı
Journal:  Endocrine       Date:  2009-10-06       Impact factor: 3.633

3.  Electrochemical immunosensor development based on core-shell high-crystalline graphitic carbon nitride@carbon dots and Cd0.5Zn0.5S/d-Ti3C2Tx MXene composite for heart-type fatty acid-binding protein detection.

Authors:  Ceren Karaman; Onur Karaman; Necip Atar; Mehmet Lütfi Yola
Journal:  Mikrochim Acta       Date:  2021-05-07       Impact factor: 5.833

4.  The utility of serum biomarkers to detect myocardial alterations induced by Imatinib in rats.

Authors:  Eugene Herman; Alan Knapton; Jun Zhang; Joel Estis; John Todd; Steven Lipshultz
Journal:  Pharmacol Res Perspect       Date:  2014-03-03

5.  Pericardial fluid levels of growth differentiation factor 15 in patients with or without coronary artery disease: a prospective study.

Authors:  Zhize Yuan; Haiqing Li; Yanjun Sun; Jiapei Qiu; Hong Xu; Jun Liu; Mi Zhou; Anqing Chen; Xiaofeng Ye; Zhe Wang; Qiang Zhao
Journal:  Ann Transl Med       Date:  2020-02

6.  Biomarkers in Acute Coronary Syndrome.

Authors:  Valentina Loria; Milena Leo; Gina Biasillo; Ilaria Dato; Luigi M Biasucci
Journal:  Biomark Insights       Date:  2008-11-05

7.  Evaluation of the cardioprotective effects of crystalloid del Nido cardioplegia solution via a rapid and accurate cardiac marker: heart-type fatty acid-binding protein

Authors:  Mehmet Kirişci; Aydemir Koçarslan; Duygun Altintaş Aykan; Filiz Alkan Baylan; Adem Doğaner; Yavuz Orak
Journal:  Turk J Med Sci       Date:  2020-06-23       Impact factor: 0.973

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.